Signant Health has launched Signant SignalSpace, a centralised environment for clinical trial data and workflows.
It aims to combine Signant applications, operational activity, support, and study data for contract research organisations (CROs), research sites, and sponsors.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The platform addresses administrative fragmentation across clinical studies, where trial teams frequently navigate disparate workflows, individual login credentials, and separate support pathways.
By establishing an integrated access point, the platform allows users to move between operational tools while maintaining context. It also provides trial sponsors and CROs with oversight across multiple programmes, products, and studies.
Within the workspace, users can interrogate datasets through an AI tool titled SHAI DataAssist.
The system uses iterative, natural language queries to review study activities and detect trends, reducing reliance on bespoke report requests, static reports, or the manual examination of downloaded files.
Signant global product management senior vice-president Spencer Jones said: “The challenge isn’t a lack of data. It’s being able to intuitively access the right information and act on it. SignalSpace gives users one connected starting point for their work, while helping sponsors and CROs connect signals across their studies and move more easily from information to insight and action.
“Signant has a strong tradition of best-in-class solutions for ePRO, eClinRO, RTSM, clinical supplies, and more. Our customers are already licensing these solutions in bundles or at a pre-determined annual volume.
“SignalSpace amplifies the value of these multi-solution agreements by making product access easier and coalescing endpoints in a single environment. SignalSpace will continue to evolve beyond today’s capabilities, bringing greater connectivity, intelligence, and efficiency across the clinical trial ecosystem.”
Signant Health provides evidence generation software and services across hybrid, traditional, and virtual trial formats.
Operating for more than 25 years, the company works with over 600 CROs and sponsors.
